Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 454-459

  Fukuura, T ^a   Miki, C ^a   Inoue, T ^a   Matsumoto, K ^a   Suzuki, H ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Hepatocyte growth factor; Immunological status; Nutritional status

Indexed keywords

HEMOGLOBIN; INTERLEUKIN 6; SCATTER FACTOR;

ADULT; AGED; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; TUMOR VOLUME; VENOUS BLOOD;

EID: 0031858674     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.514     Document Type: Article

References (69)

1. Beviglia L, Matsumoto K, Lin CS, Ziober BL and Kramer RH (1997) Expression of the c-Met/HGH receptor in human breast carcinoma, Int J Cancer 74: 301-309
2. Blood CH and Zetter BR (1990) Tumor interaction with the vasculature: angiogenesis and tumor metastasis. Biochem Biophys Acta 1032: 89-118
3. Braga M, Baccari P, Scaccabarozzi S, Fiacco E, Radaelli G, Gallus G, Dipalo S, DiCarlo V and Cristallo M (1988) Prognostic role of preoperative nutritional and immunological assessment in the surgical patient. J Parent Ent Nutr 12: 138-142
4. Bussolino F, Di Renzo MF, Ziche M, Boechietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A and Comoglio PM (1992) Hepatocytc growth factor is a potenl angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641
5. Castell JV, Gometz-Lechon MJ, David M, Horano T, Kishimoto T and Heinrich PC (1990) Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by IL-6. Hepatology 12: 1179-1186
6. Dannhauser A, Van Zyl JM and Nel CJ (1995) Preoperative nutritional status and prognostic nutritional index in patients with benign disease undergoing abdominal operations - Part II. J Am Coll Nutr 14: 91-98
7. Galeazzi E, Olivero M, Gervasio FC, De Stefani A, Valente G, Comoligo PM and Di Renzo MF (1997) Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol Suppl 1: S138-143
8. Gambardella A, Tortoricello R, Tagliamonte MR, Paolisso G and Varricchio M (1997) Metabolic changes in elderly cancer patients after glucose ingestion. The role of tumor necrosis factor-alpha. Cancer 79: 177-184
9. Gauldie J, Richards C, Harnish D, Lansdorp P and Baumann H (1987) Interferon beta2/BSH2 shares identify with monocyte derived hepatocyte stimulating factor and regulates the major acute phase protein in liver cells, Proc Natl Acad Sci USA 84: 7251-7255
10. Gherardi E and Stoker M (1990) Hepatocytes and scalter factor. Nature 346: 228
11. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S and Daikuhara Y (1986) Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Biomed Res 6: 231-237
12. Goransson J, Jonsson S and Lasson A (1996) Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery. Eur J Surg Oncol 22: 607-617
13. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P and Rosen EM (1993) Scatter factor induces blood-vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941
14. Hirota M, Egami H, Corra S, Fujii H, Chaney WG, Rizzino A and Pour PM (1993) Production of scatter factor-like activity by a nitrosamine-induccd pancreatic cancer cell line. Carcinogenesis 14: 259-264
15. Jiang WG, Hallett MB and Puntis MCA (1993) Hepatocyte growth factor, liver regeneration and cancer metastasis. Br J Surg 80: 1368-1373
16. Jin I., Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID and Rosen EM (1997) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79: 749-760
17. Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, Kubo M, Mukuda T and Fusamoto H (1992) Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy. Am J Gastroenterol 87: 1014-1017
18. Keller U (1993) Pathophysiology of cancer cachexia Supportive Care in Cancer 1: 290-294
19. Kiehne K, Herzig KH and Folsch UR (1997) c-met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas 15: 35-40
20. Liu C, Park M and Tsao MS (1992) Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene 7: 181-185
21. Mass-Szabowski N and Fusenig NE (1996) Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 107: 849-855
22. Matsumoto K, Masuda T, Terashima H, Matsumoto K, Iriyama K and Suzuki H (1988) Correlation between serum immunosuppressive substance and clinico-pathological findings in patients with gastric carcinoma. Jpn J Surg 18: 369-372
23. Matsumoto K, Tajima H, Hamanoue M, Kohno S, Kinoshita T and Nakamura T (1992) Identification and characterization of 'injurin', an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA 89: 3800-3804
24. Mayer B, Johnson J, Leitl F, Jauch KW, Heiss MM, Schildherg FW, Birchmeier W and Funke I (1993) E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53: 1690-1695
25. Miyazaki M, Bai L, Taga H, Hirai H, Sato J and Namba M (1991) Expression of liver-specific functions and secretion of a hepatocyte growth factor by a newly established rat hepatoma-cell line growing in a chemically-defined serum free medium. Res Exp Med 191: 297-307
26. Naka T, Iwamoto Y, Shinohara N, Ushijima M, Chuman H and Tsuneyoshi M (1997) Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Mod Pathol 10: 832-838
27. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y and Nakamura T (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of timor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313
28. Nishi M, Hiramatsu Y, Hioki K, Kojima Y, Sanada T, Yamanaka H and Yamamoto M (1988) Risk factors in relation to postoperative complications in patients undergoing esophagectomy or gastrectomy tor cancer. Ann Surg 207: 148-154
29. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S and Nakamura T (1990) Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biopys Res Commun 173: 42-47
30. Ohira H, Miyata M, Kuroda M, Takagi T, Tojo J, Ochiai H, Kokubun M, Nishitani T, Kasukawa R and Obara K (1996) Interleukin-6 induces proloferation of rat hepatocytes in vitro. J Hepatol 25: 941-947
31. Oka M, Mitsunaga H, Hazama S, Yoshino S and Suzuki T (1993) Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers. Jpn J Surg 23: 669-674
32. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T and Suzuki T (1996) Relationship between serum level of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 56: 2776-2801
33. Pisters LL, el-Naggar AK, Luo W, Malpica A and Lin SH (1997) C-met protooncogene expression in benign and malignant human renal tissues. J Urol 158: 724-728
34. Ramadori G, Neubauer K, Odenthal M, Nakamura T, Knittel T, Schwogler S, Meyer Z and Buschenfelde KH (1992) The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is down regulated during cell growth and by transforming growth factor beta. Biophys Res Commun 183: 739-742
35. Rosen EM, Meromsky L, Selter E, Vinter DW and Goldberg ID (1990) Purified seatter factor stimulates epithlial and vascular endothelial cell migration. Proc Soc Exp Biol Med 195: 34-43
36. Rosen EM, Meromsky L, Setter E, Vinter DW and Goldberg ID (1990b) Smooth muscle-derived factor stimulates mobility of human tumour cells. Invasion Metastasis 10: 49-64
37. Rovoltella RP, Borney F, Canto BD and D'Urso (1993) Apoptosis of serum-free C2.8 mouse embryo hepatic cells caused by hepatocyte growth factor deprivation. Cytotechnology 13: 13-19
38. Rygaard K, Nakamura T and Spang-Thomsen M (1993) Expression of the protooncogene c-met and c-kit and their ligands. hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer 67: 37-16
39. Schiffmann E (1990) Motilily as a principal requirement for metastasis. Cancer Invest 8: 673-674
40. Schirmacher P, Geerts A, Pietorangelo A, Dienes HP and Rogler CE (1992) Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 15: 5-11
41. Shibata Y, Tamura K and Ishida N (1983) In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of a I-acid glycoprotein, in connection with its high level in tumor bearing mice. Cancer Res 43: 2889-2896
42. Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A and Higashio K (1991) Tumour cytotoxic factor/hepatocyte growth factor from human recombinant protein. Biochem Biopys Res Commun 180: 1151-1158
43. Souba WW (1994) Cytokine control of nutrition and metabolism in critical illness. Curr Probl Surg 31: 577-643
44. Stoker M, Gheradi E, Perryman M and Gray J (1987) Scatter factor is a fibroblastderived modulator of epithelial cell mobility. Nature 327: 239-242
45. Strassmann G, Jacob CO, Evans R, Beall D and Fong M (1992) Mechanism of experimental cancer cachexia. Interaction between mononuclear phagocytes and eolon-26 carcinoma and its relevance to IL-6 mediated cancer cachexia. J Immunol 148: 3674-3678
46. Sugiyama A, Arakaki R, Ohhnishi T, Arakaki N, Daikuhara Y, Takada H (1996) Lipoteichoic acid and interleukin I stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblasts in culture. Infect Immun 64: 1426-1431
47. Tajima H, Matsumoto K and Nakamura T (1992) Regulation of cell growth and motilily by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202: 423-431
48. Takada N, Yano Y, Matsuda T, Otani S, Osugi H, Higashimoto M, Kinoshita H and Fukushima S (1995) Expression of immunoreactive human hepatocyte growth factor in human esophageal squamous cell carcinomas. Cancer Lett 97: 145-148
49. Tamura K, Shihata Y, Matsuda Y and Ishida N (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluid of cancer patients. Cancer Res 41: 3244-3252
50. Tamura M, Arakaki N, Tsubouchi H, Takada H and Daikuhara Y (1993) Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor -alpha by fibroblasts in culture. J Biol Chem 268: 8140-8145
51. Tanaka M, Miyazaki H, Takeda Y and Takeo S (1993) Detection of serum cytokine levels in experimental cancer cachexia of colon 26 adenocarcinoma-bearing mice. Cancer Lett 72: 65-70
52. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y and Tominaga T (1995) Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1: 1031-1034
53. Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igarl A and Toi M (1997) Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 75: 673-677
54. Tannapfel A, Wittekind C and Tahara E (1994) Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer. Z Gastroenterol 32: 91-93
55. Triantafillidis JK, Papatheodorou K, Kogevinas M, Manoussakis K and Nicolakis D (1995) Prognostic factors affecting the survival of operated patients with colorectal cancer: significance of delayed hypersensitivity skin reactions and nutritional status. Ital J Gastroenteol 27: 419-424
56. Tsao MS, Shu H, Giaid A, Viallet J and Park M (1993) Hepatocyte growth-factor/scatter factor (HGF/SF) is an autocrine factor expressed by human normal bronchial epithelial (NSB) and non small cell lung carcinoma (NSCLC) cells (abstract). FASEB J 7: 429
57. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N. Sakiyama O, Takahashi K, Kimoto M and Kawakami S (1991) Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13: 1-5
58. Ueki T, Fujimoto J, Suzuki T, Yamamoto H and Okamoto E (1997) Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 25: 862-866
59. Weidner KM, Behrens J, Vandekerckhove J and Birchmeier W (1990) Scatter factor: molecular characteristics and effect on the invasiveness of epithlial cells. J Cell Biol 111: 2097-2108
60. Weidner KM, Arakaki H, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T and Daikuhara Y (1991) Evidence for the identify of human scatter factor and hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005
61. Weng J, Mohan RR, Li Q and Wilson SE (1997) IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: inteleukin-1 beta expression in the cornea. Cornea 16: 465-471
62. Windsor JA and Hill GL (1995) Protein depletion and surgical risk. Aust NZ J Surg 147: 889-895aa
63. Wolf HK, Zarnegar R and Michalopoulous GK (1991) Localisation of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 14: 488-494
64. Yamashita J, Ogawa M and Beppu T (1993) Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer hut not in conditioned medium of human breast cancer cell lines. Res Commun Chem Pathol Pharmacol 82: 249-252
65. Yamashita J, Ogawa M, Yumashita S, Nomura N, Kuramoto M, Saishoji T and Shin S (1994) Immunoreactive hepatocyle growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633
66. Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T and Ogura T (1995) Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 71: 1095-1098
67. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K and Nakamura T (1992) Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 182: 802-809
68. Yoshinaga Y, Fujita S, Gotoh M, Nakamura T, Kikuchi M and Hirohashi S (1992) Human lung cancer cell-line producing hepatocyte growth factor/scatter factor. Jpn J Cancer Rev 83: 1257-1261
69. Zarnegar R, Muga S, Rahija R and Michalopoulous GM (1990) Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 87: 1252-1256